Elevated PRL-3 Expression Was More Frequently Detected in the Large Primary Gastric Cancer and Exhibits a Poor Prognostic Impact on the Patients

Zhao Wang,Shi-Rong Cai,Yu-Long He,Wen-Hua Zhan,Chang-Hua Zhang,Hui Wu,Jian-Jun Peng,Jian-Bo Xu,Xin-Hua Zhang,Liang Wang,Wu Song
DOI: https://doi.org/10.1007/s00432-008-0541-9
2009-01-01
Journal of Cancer Research and Clinical Oncology
Abstract:Purpose It has been reported that elevated PRL-3 expression was closely associated with lymph node metastasis of gastric cancer. In the present study, we detected the expression of PRL-3 in primary gastric cancer tissue, and evaluated its prognostic impact on the patients. Methods Total 137 gastric tumor samples were measured for PRL-3 phosphatase expression using immunohistochemistry method, and the overall survival rate was compared between the patients with high PRL-3 expression ( n = 85) and those with moderate or low PRL-3 expression ( n = 52) in the primary tumor. Results PRL-3 expression was more frequently detected in the tumors with a diameter >40 mm and in advanced stages (TNM stage III or IV). Furthermore, the overall survival rate of the patients with high expression of PRL-3 in the primary tumor was significantly less than those with moderate or low expression ( P < 0.001). Conclusions PRL-3 expression is associated with gastric cancer progression. Its high expression in the primary lesion had a negative impact on the prognosis of the patients. This strongly suggests that PRL-3 should be considered as a prognostic factor.
What problem does this paper attempt to address?